These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Diverse evolutionary roots and mechanistic variations of the CRISPR-Cas systems. Mohanraju P; Makarova KS; Zetsche B; Zhang F; Koonin EV; van der Oost J Science; 2016 Aug; 353(6299):aad5147. PubMed ID: 27493190 [TBL] [Abstract][Full Text] [Related]
3. Biology and Applications of CRISPR Systems: Harnessing Nature's Toolbox for Genome Engineering. Wright AV; Nuñez JK; Doudna JA Cell; 2016 Jan; 164(1-2):29-44. PubMed ID: 26771484 [TBL] [Abstract][Full Text] [Related]
4. Anti-CRISPRs: Protein Inhibitors of CRISPR-Cas Systems. Davidson AR; Lu WT; Stanley SY; Wang J; Mejdani M; Trost CN; Hicks BT; Lee J; Sontheimer EJ Annu Rev Biochem; 2020 Jun; 89():309-332. PubMed ID: 32186918 [TBL] [Abstract][Full Text] [Related]
5. Five big mysteries about CRISPR's origins. Ledford H Nature; 2017 Jan; 541(7637):280-282. PubMed ID: 28102279 [No Abstract] [Full Text] [Related]
6. Structural plasticity and in vivo activity of Cas1 from the type I-F CRISPR-Cas system. Wilkinson ME; Nakatani Y; Staals RH; Kieper SN; Opel-Reading HK; McKenzie RE; Fineran PC; Krause KL Biochem J; 2016 Apr; 473(8):1063-72. PubMed ID: 26929403 [TBL] [Abstract][Full Text] [Related]
7. Cas1 and Cas2 From the Type II-C CRISPR-Cas System of He Y; Wang M; Liu M; Huang L; Liu C; Zhang X; Yi H; Cheng A; Zhu D; Yang Q; Wu Y; Zhao X; Chen S; Jia R; Zhang S; Liu Y; Yu Y; Zhang L Front Cell Infect Microbiol; 2018; 8():195. PubMed ID: 29951376 [TBL] [Abstract][Full Text] [Related]
8. How type II CRISPR-Cas establish immunity through Cas1-Cas2-mediated spacer integration. Xiao Y; Ng S; Nam KH; Ke A Nature; 2017 Oct; 550(7674):137-141. PubMed ID: 28869593 [TBL] [Abstract][Full Text] [Related]
9. CRISPR-Cas adaptation: insights into the mechanism of action. Amitai G; Sorek R Nat Rev Microbiol; 2016 Feb; 14(2):67-76. PubMed ID: 26751509 [TBL] [Abstract][Full Text] [Related]
10. Classification and evolution of type II CRISPR-Cas systems. Chylinski K; Makarova KS; Charpentier E; Koonin EV Nucleic Acids Res; 2014 Jun; 42(10):6091-105. PubMed ID: 24728998 [TBL] [Abstract][Full Text] [Related]
11. Adapting to new threats: the generation of memory by CRISPR-Cas immune systems. Heler R; Marraffini LA; Bikard D Mol Microbiol; 2014 Jul; 93(1):1-9. PubMed ID: 24806524 [TBL] [Abstract][Full Text] [Related]
12. Fidelity of prespacer capture and processing is governed by the PAM-mediated interactions of Cas1-2 adaptation complex in CRISPR-Cas type I-E system. Yoganand KN; Muralidharan M; Nimkar S; Anand B J Biol Chem; 2019 Dec; 294(52):20039-20053. PubMed ID: 31748409 [TBL] [Abstract][Full Text] [Related]
14. On the Origin of Reverse Transcriptase-Using CRISPR-Cas Systems and Their Hyperdiverse, Enigmatic Spacer Repertoires. Silas S; Makarova KS; Shmakov S; Páez-Espino D; Mohr G; Liu Y; Davison M; Roux S; Krishnamurthy SR; Fu BXH; Hansen LL; Wang D; Sullivan MB; Millard A; Clokie MR; Bhaya D; Lambowitz AM; Kyrpides NC; Koonin EV; Fire AZ mBio; 2017 Jul; 8(4):. PubMed ID: 28698278 [TBL] [Abstract][Full Text] [Related]
15. Unravelling the structural and mechanistic basis of CRISPR-Cas systems. van der Oost J; Westra ER; Jackson RN; Wiedenheft B Nat Rev Microbiol; 2014 Jul; 12(7):479-92. PubMed ID: 24909109 [TBL] [Abstract][Full Text] [Related]
16. Direct CRISPR spacer acquisition from RNA by a natural reverse transcriptase-Cas1 fusion protein. Silas S; Mohr G; Sidote DJ; Markham LM; Sanchez-Amat A; Bhaya D; Lambowitz AM; Fire AZ Science; 2016 Feb; 351(6276):aad4234. PubMed ID: 26917774 [TBL] [Abstract][Full Text] [Related]
17. The roles of CRISPR-Cas systems in adaptive immunity and beyond. Barrangou R Curr Opin Immunol; 2015 Feb; 32():36-41. PubMed ID: 25574773 [TBL] [Abstract][Full Text] [Related]
18. Meet the Anti-CRISPRs: Widespread Protein Inhibitors of CRISPR-Cas Systems. Hwang S; Maxwell KL CRISPR J; 2019 Feb; 2(1):23-30. PubMed ID: 31021234 [TBL] [Abstract][Full Text] [Related]
19. Cutting it close: CRISPR-associated endoribonuclease structure and function. Hochstrasser ML; Doudna JA Trends Biochem Sci; 2015 Jan; 40(1):58-66. PubMed ID: 25468820 [TBL] [Abstract][Full Text] [Related]
20. Clustered regularly interspaced short palindromic repeats (CRISPRs): the hallmark of an ingenious antiviral defense mechanism in prokaryotes. Al-Attar S; Westra ER; van der Oost J; Brouns SJ Biol Chem; 2011 Apr; 392(4):277-89. PubMed ID: 21294681 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]